A 2023 analysis of GLP-1 use in oncology patients found no absolute contraindications with endocrine therapies, though individualized monitoring was recommended
Dehydration represents a clinically significant risk for patients taking GLP-1 medications, particularly during the initial weeks of therapy or following dose increases when gastrointestinal side effects are most pronounced
What should I expect in the first few weeks of the dose escalation
Tirzepatide Prescription for Weight Loss Discover the potential of tirzepatide, also known as Zepbound, for weight loss through Klinic's telehealth services in Tomball, Texas
It's currently labeled as a category 2 substance, meaning that the FDA has identified an ingredient as having a possible safety risk and it cannot be used in compounded medications
Moreover, the applicant noted that anterior lumbar approaches are currently assigned to the Medicare Inpatient Only list and may not be performed in the outpatient setting